Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder

Psychiatry Research

Volumn 190, Issue 2-3, 2011, Pages 253-258

  Teter, Christian J ^a,b   Falone, Anthony E ^a,c   Bakaian, Amanda M ^b   Tu, Chunhao ^b   Öngür, Dost ^a   Weiss, Roger D ^a,d  

^a MCLEAN HOSPITAL   (United States)

^b UNIVERSITY OF NEW ENGLAND   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Addiction; Attitude; Comorbidity; Compliance; Mood disorder; Pharmacotherapy

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; HALOPERIDOL; LITHIUM SALT; LORAZEPAM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; RISPERIDONE; TOPIRAMATE; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR MANIA; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MIXED MANIA AND DEPRESSION; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PATIENT COMPLIANCE; POST HOC ANALYSIS; PRIORITY JOURNAL; SUBSTANCE ABUSE;

ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; BIPOLAR DISORDER; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SUBSTANCE-RELATED DISORDERS;

EID: 82955203388     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.05.042     Document Type: Article

References (30)

1. Agresti A., Bini M., Bertaccini B., Ryu E. Simultaneous confidence intervals for comparing binomial parameters. Biometrics 2008, 64:1270-1275.
2. Baldessarini R.J., Perry R., Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Human Psychopharmacology 2008, 23:95-105.
3. Clatworthy J., Bowskill R., Parham R., Rank T., Scott J., Horne R. Understanding medication non-adherence in bipolar disorders using a Necessity-Concerns Framework. Journal of Affective Disorders 2009, 116:51-55.
4. Efron B., Tibshirani R.J. An Introduction to the Bootstrap 1993, Chapman & Hall/CRC Press, Boca Raton, Fl.
5. First M.B., Spitzer R.L., Gibbon M., Williams J. Structured Clinical Interview for DSM-IV (SCID-I) (User's Guide and Interview) Research Version 1995, Biometrics Research Department, New York State Psychiatric Institute, New York.
6. Gaudiano B.A., Uebelacker L.A., Miller I.W. Impact of remitted substance use disorders on the future course of bipolar I disorder: findings from a clinical trial. Psychiatry Research 2008, 160:63-71.
7. Gianfrancesco F.D., Sajatovic M., Tafesse E., Wang R.H. Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder. Annals of Clinical Psychiatry 2009, 21:3-16.
8. Goldberg J.F., Garno J.L., Leon A.C., Kocsis J.H., Portera L. A history of substance abuse complicates remission from acute mania in bipolar disorder. Journal of Clinical Psychiatry 1999, 60:733-740.
9. Grant B.F., Stinson F.S., Hasin D.S., Dawson D.A., Chou S.P., Ruan W.J., Huang B. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 2005, 66:1205-1215.
10. Hogan T.P., Awad A.G. Drug Attitude Inventory. Handbook of psychiatric measures 2000, American Psychiatric Association Publishing, Arlington, VA. A.J. Rush (Ed.).
11. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
12. Keck P.E., McElroy S.L., Strakowski S.M., Stanton S.P., Kizer D.L., Balistreri T.M., Bennett J.A., Tugrul K.C., West S.A. Factors associated with pharmacologic noncompliance in patients with mania. Journal of Clinical Psychiatry 1996, 7:292-297.
13. Keck P.E., McElroy S.L., Strakowski S.M., Bourne M.L., West S.A. Compliance with maintenance treatment in bipolar disorder. Psychopharmacology Bulletin 1997, 33:87-91.
14. Kessler R.C., Crum R.M., Warner L.A., Nelson C.B., Schulenberg J., Anthony J.C. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry 1997, 54:313-321.
15. Lagerberg T.V., Andreassen O.A., Ringen P.A., Berg A.O., Larsson S., Agartz I., Sundet K., Melle I. Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study. BMC Psychiatry 2010, 10(9):1-9.
16. Levy B., Monzani B.A., Stephansky M.R., Weiss R.D. Neurocognitive impairment in patients with co-occurring bipolar disorder and alcohol dependence upon discharge from inpatient care. Psychiatry Research 2008, 161:28-35.
17. Manwani S.G., Szilagyi K.A., Zablotsky B., Hennen J., Griffin M.L., Weiss R.D. Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. Journal of Clinical Psychiatry 2007, 68:1172-1176.
18. Montgomery S.A., Åsberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979, 134:382-389.
19. Öngür D., Lin L., Cohen B.M. Clinical characteristics influencing age at onset in psychotic disorders. Comprehensive Psychiatry 2008, 50:13-19.
20. Perlis R.H., Ostacher M.J., Miklowitz D.J., Hay A., Nierenberg A.A., Thase M.E., Sachs G.S. Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study. Journal of Clinical Psychiatry 2010, 71:296-303.
21. Pomykacz B., Mao M., Weiss R.D., Teter C.J. A review of brief medication-adherence instruments used in patients with schizophrenia and bipolar disorder. Harvard Review of Psychiatry 2007, 15:259-263.
22. R Development Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing 2010, Vienna, Austria. ISBN 3-900051-07-0. Available at: http://www.R-project.org (accessed 12-6-2010).
23. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990, 264:2511-2518.
24. Sajatovic M., Bauer M.S., Kilbourne A.M., Vertrees J.E., Williford W. Self-reported medication treatment adherence among veterans with bipolar disorder. Psychiatric Services 2006, 57:56-62.
25. Sajatovic M., Ignacio R.V., West J.A., Cassidy K.A., Safavi R., Kilbourne A.M., Blow F.C. Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Comprehensive Psychiatry 2009, 50:100-107.
26. Scott J., Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. American Journal of Psychiatry 2002, 159:1927-1929.
27. Weiss R.D. Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction 2004, 99:1382-1392.
28. Weiss R.D., Greenfield S.F., Najavits L.M. Medication compliance among patients with bipolar disorder and substance use disorder. Journal of Clinical Psychiatry 1998, 59:172-174.
29. Weiss R.D., Ostacher M.J., Otto M.W., Calabrese J.R., Fossey M., Wisniewski S.R., Bowden C.L., Nierenberg A.A., Pollack M.H., Salloum I.M., Simon N.M., Thase M.E., Sachs G.S. Does recovery from substance use disorder matter in patients with bipolar disorder?. Journal of Clinical Psychiatry 2005, 66:730-735. for STEP-BD Investigators.
30. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 1978, 133:429-435.